Rank | Gene Set | Z-score |
---|---|---|
1 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.08291586 |
2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.94386869 |
3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.94314633 |
4 | protein maturation by protein folding (GO:0022417) | 4.57008539 |
5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.48360559 |
6 | synaptic vesicle exocytosis (GO:0016079) | 4.34551185 |
7 | detection of calcium ion (GO:0005513) | 4.25377133 |
8 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.20056522 |
9 | nucleobase catabolic process (GO:0046113) | 4.14466901 |
10 | vocalization behavior (GO:0071625) | 4.10762986 |
11 | neuron cell-cell adhesion (GO:0007158) | 4.07904412 |
12 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.06948470 |
13 | neuronal action potential propagation (GO:0019227) | 4.02364049 |
14 | COPI coating of Golgi vesicle (GO:0048205) | 4.01391357 |
15 | Golgi transport vesicle coating (GO:0048200) | 4.01391357 |
16 | regulation of synaptic vesicle transport (GO:1902803) | 3.96579192 |
17 | synaptic vesicle maturation (GO:0016188) | 3.94497842 |
18 | response to auditory stimulus (GO:0010996) | 3.92631357 |
19 | positive regulation of action potential (GO:0045760) | 3.85403288 |
20 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.85138659 |
21 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.84538992 |
22 | presynaptic membrane assembly (GO:0097105) | 3.81774315 |
23 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.79617707 |
24 | urinary tract smooth muscle contraction (GO:0014848) | 3.79172744 |
25 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.73935866 |
26 | locomotory exploration behavior (GO:0035641) | 3.69837170 |
27 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.69539344 |
28 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.63494463 |
29 | glutamate secretion (GO:0014047) | 3.62135379 |
30 | membrane depolarization during action potential (GO:0086010) | 3.60700552 |
31 | regulation of synapse structural plasticity (GO:0051823) | 3.58614116 |
32 | neurofilament cytoskeleton organization (GO:0060052) | 3.57695531 |
33 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.56824768 |
34 | insulin secretion (GO:0030073) | 3.56318388 |
35 | protein localization to synapse (GO:0035418) | 3.54785046 |
36 | postsynaptic membrane organization (GO:0001941) | 3.54291896 |
37 | cerebellar granule cell differentiation (GO:0021707) | 3.53806149 |
38 | neurotransmitter secretion (GO:0007269) | 3.53508791 |
39 | auditory behavior (GO:0031223) | 3.49516691 |
40 | tachykinin receptor signaling pathway (GO:0007217) | 3.45847258 |
41 | neuromuscular synaptic transmission (GO:0007274) | 3.45738354 |
42 | inner ear receptor cell development (GO:0060119) | 3.45433408 |
43 | activation of protein kinase A activity (GO:0034199) | 3.43227200 |
44 | peptide hormone processing (GO:0016486) | 3.42116857 |
45 | presynaptic membrane organization (GO:0097090) | 3.40075210 |
46 | cell migration in hindbrain (GO:0021535) | 3.39792471 |
47 | chemosensory behavior (GO:0007635) | 3.38987285 |
48 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.38187220 |
49 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.37452559 |
50 | neuron recognition (GO:0008038) | 3.37049518 |
51 | regulation of vesicle fusion (GO:0031338) | 3.36540128 |
52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.36358217 |
53 | righting reflex (GO:0060013) | 3.35874297 |
54 | cellular potassium ion homeostasis (GO:0030007) | 3.34727990 |
55 | glutamate receptor signaling pathway (GO:0007215) | 3.34184011 |
56 | neuron-neuron synaptic transmission (GO:0007270) | 3.30486520 |
57 | synaptic transmission, glutamatergic (GO:0035249) | 3.30110055 |
58 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.29359245 |
59 | dendrite morphogenesis (GO:0048813) | 3.28546016 |
60 | neuronal ion channel clustering (GO:0045161) | 3.27595419 |
61 | exploration behavior (GO:0035640) | 3.23145979 |
62 | dendritic spine morphogenesis (GO:0060997) | 3.20678071 |
63 | sodium ion export (GO:0071436) | 3.18255503 |
64 | cerebellar Purkinje cell layer development (GO:0021680) | 3.17678563 |
65 | membrane depolarization (GO:0051899) | 3.17329276 |
66 | L-amino acid import (GO:0043092) | 3.16653645 |
67 | negative regulation of dendrite development (GO:2000171) | 3.16632706 |
68 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.15722048 |
69 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.15495730 |
70 | short-term memory (GO:0007614) | 3.15461066 |
71 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.15353929 |
72 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.14912607 |
73 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.14204262 |
74 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.14152064 |
75 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.13593955 |
76 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.13035261 |
77 | endocrine pancreas development (GO:0031018) | 3.11052859 |
78 | innervation (GO:0060384) | 3.10563509 |
79 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.08288725 |
80 | regulation of insulin secretion (GO:0050796) | 3.08106245 |
81 | positive regulation of exocytosis (GO:0045921) | 3.05827575 |
82 | adult walking behavior (GO:0007628) | 3.05760299 |
83 | protein targeting to Golgi (GO:0000042) | 3.03373558 |
84 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.01778384 |
85 | long-term memory (GO:0007616) | 3.01471971 |
86 | regulation of neurotransmitter transport (GO:0051588) | 3.01395223 |
87 | positive regulation of membrane potential (GO:0045838) | 2.99796139 |
88 | transmission of nerve impulse (GO:0019226) | 2.99162049 |
89 | neurotransmitter transport (GO:0006836) | 2.98873420 |
90 | regulation of action potential (GO:0098900) | 2.98394070 |
91 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.98104154 |
92 | long-term synaptic potentiation (GO:0060291) | 2.97438858 |
93 | regulation of exocytosis (GO:0017157) | 2.96242124 |
94 | synapse organization (GO:0050808) | 2.96023014 |
95 | positive regulation of vascular permeability (GO:0043117) | 2.95404147 |
96 | vesicle transport along microtubule (GO:0047496) | 2.95394005 |
97 | behavioral fear response (GO:0001662) | 2.94920227 |
98 | behavioral defense response (GO:0002209) | 2.94920227 |
99 | cellular sodium ion homeostasis (GO:0006883) | 2.94847103 |
100 | positive regulation of synapse maturation (GO:0090129) | 2.94431402 |
101 | positive regulation of dendritic spine development (GO:0060999) | 2.93048094 |
102 | startle response (GO:0001964) | 2.92512239 |
103 | proline transport (GO:0015824) | 2.91543341 |
104 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.90961799 |
105 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.89879940 |
106 | retinal cone cell development (GO:0046549) | 2.89562601 |
107 | aggressive behavior (GO:0002118) | 2.89359010 |
108 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.89128237 |
109 | synaptic transmission (GO:0007268) | 2.88495659 |
110 | positive regulation of neurotransmitter transport (GO:0051590) | 2.87240332 |
111 | establishment of mitochondrion localization (GO:0051654) | 2.86932776 |
112 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.85878127 |
113 | cellular response to glucagon stimulus (GO:0071377) | 2.84336091 |
114 | layer formation in cerebral cortex (GO:0021819) | 2.84050064 |
115 | regulation of postsynaptic membrane potential (GO:0060078) | 2.83782098 |
116 | negative regulation of norepinephrine secretion (GO:0010700) | 2.83200841 |
117 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.80288747 |
118 | axonal fasciculation (GO:0007413) | 2.79182178 |
119 | regulation of peptide hormone secretion (GO:0090276) | 2.78658486 |
120 | negative regulation of catecholamine secretion (GO:0033604) | 2.78619258 |
121 | regulation of peptide secretion (GO:0002791) | 2.77382883 |
122 | positive regulation of insulin secretion (GO:0032024) | 2.77375994 |
123 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.77054788 |
124 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.77054788 |
125 | synaptic vesicle endocytosis (GO:0048488) | 2.76970641 |
126 | regulation of beta-amyloid formation (GO:1902003) | 2.76596735 |
127 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.74400594 |
128 | organelle transport along microtubule (GO:0072384) | 2.73311665 |
129 | regulation of neurotransmitter secretion (GO:0046928) | 2.72973480 |
130 | signal release (GO:0023061) | 2.72691479 |
131 | neuromuscular process controlling posture (GO:0050884) | 2.72437058 |
132 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.72283877 |
133 | regulation of synaptic plasticity (GO:0048167) | 2.71573601 |
134 | positive regulation of vesicle fusion (GO:0031340) | 2.71456620 |
135 | negative regulation of amine transport (GO:0051953) | 2.70969170 |
136 | suckling behavior (GO:0001967) | 2.70627366 |
137 | response to histamine (GO:0034776) | 2.70069481 |
138 | establishment of protein localization to Golgi (GO:0072600) | 2.69841688 |
139 | ER overload response (GO:0006983) | 2.68406563 |
140 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.67128011 |
141 | cochlea development (GO:0090102) | 2.66893980 |
142 | peptide hormone secretion (GO:0030072) | 2.64222067 |
143 | regulation of neurotransmitter levels (GO:0001505) | 2.64190587 |
144 | cerebellum development (GO:0021549) | 2.63728182 |
145 | gamma-aminobutyric acid transport (GO:0015812) | 2.63395273 |
146 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.61161756 |
147 | synapse assembly (GO:0007416) | 2.60875837 |
148 | fear response (GO:0042596) | 2.60581451 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.74713457 |
2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.56445095 |
3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.90107815 |
4 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.90075590 |
5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.86927724 |
6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.77193991 |
7 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.74219506 |
8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.42179255 |
9 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42144112 |
10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41430715 |
11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37464350 |
12 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.31660989 |
13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.28240016 |
14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.26988676 |
15 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.24328469 |
16 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.21371000 |
17 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.21371000 |
18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.21297172 |
19 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.19191226 |
20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.12851834 |
21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.12284918 |
22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.12057086 |
23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.11495069 |
24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05523646 |
25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.03528300 |
26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.97679225 |
27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.92190787 |
28 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.88865979 |
29 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86627875 |
30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.85540118 |
31 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.81886427 |
32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.80243509 |
33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79697306 |
34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78415210 |
35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77283274 |
36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.69773073 |
37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.64496697 |
38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.62374574 |
39 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.59491210 |
40 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.58131717 |
41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53624930 |
42 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52380848 |
43 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.52018912 |
44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.51871342 |
45 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50693121 |
46 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47024168 |
47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44883443 |
48 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36909812 |
49 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36596658 |
50 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.36457027 |
51 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30518150 |
52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29801499 |
53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27948880 |
54 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26403151 |
55 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.26403151 |
56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.23518087 |
57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23452606 |
58 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.21146213 |
59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20838249 |
60 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20055106 |
61 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19438346 |
62 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19105625 |
63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18856830 |
64 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.18601930 |
65 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.18205377 |
66 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.18126013 |
67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18094193 |
68 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17336764 |
69 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17336764 |
70 | * AR_19668381_ChIP-Seq_PC3_Human | 1.16839966 |
71 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.15609337 |
72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14986278 |
73 | EWS_26573619_Chip-Seq_HEK293_Human | 1.14624647 |
74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13640895 |
75 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12804954 |
76 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11159893 |
77 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.10602500 |
78 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.10188567 |
79 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09796898 |
80 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.09411931 |
81 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09166825 |
82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08900575 |
83 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.08608896 |
84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07833818 |
85 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07543841 |
86 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07171142 |
87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07012387 |
88 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02804556 |
89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02444185 |
90 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02029150 |
91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02012875 |
92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01236190 |
93 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01014779 |
94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99932981 |
95 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.98695794 |
96 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98513810 |
97 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98312060 |
98 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.97655611 |
99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97604815 |
100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96904860 |
101 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96364023 |
102 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96216142 |
103 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95729488 |
104 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95228073 |
105 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95041312 |
106 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94379771 |
107 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.94350436 |
108 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93516042 |
109 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93146204 |
110 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92744828 |
111 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91698867 |
112 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91247985 |
113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90293581 |
114 | JUN_21703547_ChIP-Seq_K562_Human | 0.89618395 |
115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88072942 |
116 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84947363 |
117 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84486245 |
118 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84321784 |
119 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.84261447 |
120 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.84030005 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.15736305 |
2 | MP0003880_abnormal_central_pattern | 4.11060640 |
3 | MP0003635_abnormal_synaptic_transmissio | 3.34505364 |
4 | MP0004270_analgesia | 3.28065075 |
5 | MP0002909_abnormal_adrenal_gland | 3.22652234 |
6 | MP0009780_abnormal_chondrocyte_physiolo | 3.14994251 |
7 | MP0000013_abnormal_adipose_tissue | 2.64813142 |
8 | MP0009745_abnormal_behavioral_response | 2.64163504 |
9 | MP0002063_abnormal_learning/memory/cond | 2.62358094 |
10 | MP0002837_dystrophic_cardiac_calcinosis | 2.60848064 |
11 | MP0004043_abnormal_pH_regulation | 2.48689228 |
12 | MP0010386_abnormal_urinary_bladder | 2.48445505 |
13 | MP0002064_seizures | 2.47421062 |
14 | MP0003283_abnormal_digestive_organ | 2.47400259 |
15 | MP0002572_abnormal_emotion/affect_behav | 2.36685267 |
16 | MP0009046_muscle_twitch | 2.26304463 |
17 | MP0002272_abnormal_nervous_system | 2.24108808 |
18 | MP0001968_abnormal_touch/_nociception | 2.23691595 |
19 | MP0002734_abnormal_mechanical_nocicepti | 2.23583998 |
20 | MP0001501_abnormal_sleep_pattern | 2.22429537 |
21 | MP0005379_endocrine/exocrine_gland_phen | 2.17018502 |
22 | MP0002693_abnormal_pancreas_physiology | 2.16393069 |
23 | MP0003122_maternal_imprinting | 2.13513712 |
24 | MP0005646_abnormal_pituitary_gland | 2.10942246 |
25 | MP0006276_abnormal_autonomic_nervous | 2.01517052 |
26 | MP0002877_abnormal_melanocyte_morpholog | 2.00716132 |
27 | MP0002876_abnormal_thyroid_physiology | 1.97752759 |
28 | MP0005645_abnormal_hypothalamus_physiol | 1.95949042 |
29 | MP0002733_abnormal_thermal_nociception | 1.89037513 |
30 | MP0001944_abnormal_pancreas_morphology | 1.85983565 |
31 | MP0001486_abnormal_startle_reflex | 1.79101318 |
32 | MP0005423_abnormal_somatic_nervous | 1.75043863 |
33 | MP0001970_abnormal_pain_threshold | 1.72258288 |
34 | MP0002735_abnormal_chemical_nociception | 1.70535347 |
35 | * MP0002067_abnormal_sensory_capabilities | 1.68262530 |
36 | MP0002736_abnormal_nociception_after | 1.66360950 |
37 | MP0001440_abnormal_grooming_behavior | 1.64737303 |
38 | MP0003787_abnormal_imprinting | 1.59010243 |
39 | MP0003329_amyloid_beta_deposits | 1.57882680 |
40 | MP0000678_abnormal_parathyroid_gland | 1.55344745 |
41 | MP0004742_abnormal_vestibular_system | 1.55114469 |
42 | MP0006072_abnormal_retinal_apoptosis | 1.55106401 |
43 | MP0002184_abnormal_innervation | 1.54684557 |
44 | MP0002557_abnormal_social/conspecific_i | 1.54186670 |
45 | MP0001529_abnormal_vocalization | 1.53034523 |
46 | MP0003183_abnormal_peptide_metabolism | 1.52550703 |
47 | MP0000569_abnormal_digit_pigmentation | 1.52520419 |
48 | MP0001502_abnormal_circadian_rhythm | 1.48707093 |
49 | MP0003879_abnormal_hair_cell | 1.47805225 |
50 | MP0001984_abnormal_olfaction | 1.46830907 |
51 | MP0003195_calcinosis | 1.44944073 |
52 | MP0005386_behavior/neurological_phenoty | 1.40273593 |
53 | MP0004924_abnormal_behavior | 1.40273593 |
54 | MP0000955_abnormal_spinal_cord | 1.35790925 |
55 | MP0008877_abnormal_DNA_methylation | 1.29383476 |
56 | MP0002638_abnormal_pupillary_reflex | 1.28792240 |
57 | MP0008569_lethality_at_weaning | 1.26648459 |
58 | MP0005535_abnormal_body_temperature | 1.25912116 |
59 | MP0002078_abnormal_glucose_homeostasis | 1.25537476 |
60 | MP0004811_abnormal_neuron_physiology | 1.24318592 |
61 | MP0000778_abnormal_nervous_system | 1.23882746 |
62 | MP0001188_hyperpigmentation | 1.23708450 |
63 | MP0000631_abnormal_neuroendocrine_gland | 1.17698295 |
64 | * MP0002066_abnormal_motor_capabilities/c | 1.17536558 |
65 | MP0002882_abnormal_neuron_morphology | 1.13171978 |
66 | MP0008872_abnormal_physiological_respon | 1.09951751 |
67 | MP0003633_abnormal_nervous_system | 1.09107728 |
68 | MP0004145_abnormal_muscle_electrophysio | 1.07802331 |
69 | MP0005248_abnormal_Harderian_gland | 1.07235085 |
70 | MP0001765_abnormal_ion_homeostasis | 1.05882296 |
71 | MP0002822_catalepsy | 1.05592872 |
72 | MP0001299_abnormal_eye_distance/ | 1.04947299 |
73 | MP0001346_abnormal_lacrimal_gland | 1.04655249 |
74 | MP0002102_abnormal_ear_morphology | 1.04652614 |
75 | MP0002234_abnormal_pharynx_morphology | 1.03987716 |
76 | MP0002752_abnormal_somatic_nervous | 1.02897318 |
77 | MP0002229_neurodegeneration | 1.01999884 |
78 | MP0004858_abnormal_nervous_system | 1.00851427 |
79 | MP0003868_abnormal_feces_composition | 0.99808446 |
80 | MP0002751_abnormal_autonomic_nervous | 0.99681704 |
81 | MP0002069_abnormal_eating/drinking_beha | 0.97308435 |
82 | MP0003119_abnormal_digestive_system | 0.97210506 |
83 | MP0002653_abnormal_ependyma_morphology | 0.95090451 |
84 | MP0004142_abnormal_muscle_tone | 0.94491919 |
85 | MP0003172_abnormal_lysosome_physiology | 0.92937379 |
86 | MP0000003_abnormal_adipose_tissue | 0.92643710 |
87 | MP0008961_abnormal_basal_metabolism | 0.91901638 |
88 | MP0001986_abnormal_taste_sensitivity | 0.91871738 |
89 | MP0003953_abnormal_hormone_level | 0.91421943 |
90 | MP0001905_abnormal_dopamine_level | 0.90068222 |
91 | MP0001177_atelectasis | 0.87860025 |
92 | MP0001348_abnormal_lacrimal_gland | 0.87633016 |
93 | MP0005551_abnormal_eye_electrophysiolog | 0.87319397 |
94 | MP0004085_abnormal_heartbeat | 0.86878448 |
95 | MP0005187_abnormal_penis_morphology | 0.85056886 |
96 | MP0002163_abnormal_gland_morphology | 0.83025152 |
97 | MP0005171_absent_coat_pigmentation | 0.82621655 |
98 | MP0003861_abnormal_nervous_system | 0.81573988 |
99 | MP0002152_abnormal_brain_morphology | 0.81398484 |
100 | MP0005253_abnormal_eye_physiology | 0.80768643 |
101 | MP0003634_abnormal_glial_cell | 0.79674964 |
102 | MP0003631_nervous_system_phenotype | 0.79439614 |
103 | MP0001664_abnormal_digestion | 0.78158344 |
104 | MP0004885_abnormal_endolymph | 0.77550611 |
105 | MP0003121_genomic_imprinting | 0.74377882 |
106 | MP0005394_taste/olfaction_phenotype | 0.73900132 |
107 | MP0005499_abnormal_olfactory_system | 0.73900132 |
108 | MP0000026_abnormal_inner_ear | 0.73688246 |
109 | MP0003632_abnormal_nervous_system | 0.73435268 |
110 | MP0004147_increased_porphyrin_level | 0.71849826 |
111 | MP0005448_abnormal_energy_balance | 0.70999815 |
112 | MP0005623_abnormal_meninges_morphology | 0.70133651 |
113 | MP0003123_paternal_imprinting | 0.69714766 |
114 | MP0003136_yellow_coat_color | 0.69039254 |
115 | MP0001963_abnormal_hearing_physiology | 0.68546599 |
116 | MP0008789_abnormal_olfactory_epithelium | 0.66772214 |
117 | MP0005220_abnormal_exocrine_pancreas | 0.66127192 |
118 | MP0003890_abnormal_embryonic-extraembry | 0.65626476 |
119 | MP0001485_abnormal_pinna_reflex | 0.65008299 |
120 | MP0000230_abnormal_systemic_arterial | 0.64115536 |
121 | MP0003938_abnormal_ear_development | 0.63098813 |
122 | * MP0001943_abnormal_respiration | 0.63061144 |
123 | MP0000372_irregular_coat_pigmentation | 0.62201934 |
124 | MP0002277_abnormal_respiratory_mucosa | 0.61874174 |
125 | MP0000604_amyloidosis | 0.59960408 |
126 | MP0000534_abnormal_ureter_morphology | 0.59762571 |
127 | MP0002082_postnatal_lethality | 0.59191327 |
128 | MP0010770_preweaning_lethality | 0.59191327 |
129 | MP0000920_abnormal_myelination | 0.58096922 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 5.95836734 |
2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.10157451 |
3 | Visual hallucinations (HP:0002367) | 4.98026056 |
4 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.67200350 |
5 | Atonic seizures (HP:0010819) | 4.57205180 |
6 | Focal seizures (HP:0007359) | 4.01688780 |
7 | Absence seizures (HP:0002121) | 3.98178808 |
8 | Hypoglycemic seizures (HP:0002173) | 3.89159496 |
9 | Epileptic encephalopathy (HP:0200134) | 3.69763618 |
10 | Symptomatic seizures (HP:0011145) | 3.62889690 |
11 | Dialeptic seizures (HP:0011146) | 3.47499931 |
12 | Epileptiform EEG discharges (HP:0011182) | 3.43538689 |
13 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.38926321 |
14 | EEG with generalized epileptiform discharges (HP:0011198) | 3.36402801 |
15 | Agitation (HP:0000713) | 3.32929239 |
16 | Spastic gait (HP:0002064) | 3.30776364 |
17 | Generalized tonic-clonic seizures (HP:0002069) | 3.29559275 |
18 | Decreased circulating renin level (HP:0003351) | 3.25795290 |
19 | Febrile seizures (HP:0002373) | 3.23586611 |
20 | Hypsarrhythmia (HP:0002521) | 3.16904215 |
21 | Myokymia (HP:0002411) | 3.13115826 |
22 | Oligodactyly (hands) (HP:0001180) | 3.12213753 |
23 | Abnormality of the corticospinal tract (HP:0002492) | 3.12112004 |
24 | Ankle clonus (HP:0011448) | 3.09983623 |
25 | Papilledema (HP:0001085) | 3.05314889 |
26 | Supranuclear gaze palsy (HP:0000605) | 3.03570179 |
27 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.02452965 |
28 | Urinary urgency (HP:0000012) | 2.93497896 |
29 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.88451442 |
30 | Hyperventilation (HP:0002883) | 2.84493126 |
31 | Cerebral inclusion bodies (HP:0100314) | 2.84350775 |
32 | Pheochromocytoma (HP:0002666) | 2.81482714 |
33 | Progressive cerebellar ataxia (HP:0002073) | 2.80091403 |
34 | Truncal ataxia (HP:0002078) | 2.78086564 |
35 | Anxiety (HP:0000739) | 2.77836378 |
36 | Neurofibrillary tangles (HP:0002185) | 2.71271316 |
37 | Depression (HP:0000716) | 2.70007343 |
38 | Drooling (HP:0002307) | 2.68169284 |
39 | Excessive salivation (HP:0003781) | 2.68169284 |
40 | Polyphagia (HP:0002591) | 2.67310753 |
41 | Mutism (HP:0002300) | 2.65994891 |
42 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.57687433 |
43 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.57687433 |
44 | Amblyopia (HP:0000646) | 2.56460406 |
45 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.53121755 |
46 | Status epilepticus (HP:0002133) | 2.52758982 |
47 | Ketoacidosis (HP:0001993) | 2.51310596 |
48 | Lower limb muscle weakness (HP:0007340) | 2.48962896 |
49 | Impaired smooth pursuit (HP:0007772) | 2.47714695 |
50 | Hyperglycemia (HP:0003074) | 2.47096874 |
51 | Intention tremor (HP:0002080) | 2.45065614 |
52 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.42088667 |
53 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.42088667 |
54 | Hypoglycemic coma (HP:0001325) | 2.41941685 |
55 | Large for gestational age (HP:0001520) | 2.37292869 |
56 | Neuroendocrine neoplasm (HP:0100634) | 2.36852476 |
57 | Hemiparesis (HP:0001269) | 2.32419908 |
58 | Gait imbalance (HP:0002141) | 2.31841295 |
59 | Akinesia (HP:0002304) | 2.31156211 |
60 | Abnormality of the labia minora (HP:0012880) | 2.29528506 |
61 | Intestinal atresia (HP:0011100) | 2.28528456 |
62 | Impaired vibratory sensation (HP:0002495) | 2.26838198 |
63 | Protruding tongue (HP:0010808) | 2.26775552 |
64 | Action tremor (HP:0002345) | 2.26036151 |
65 | Genetic anticipation (HP:0003743) | 2.24561203 |
66 | Hypokalemia (HP:0002900) | 2.24191447 |
67 | Torticollis (HP:0000473) | 2.23643440 |
68 | Medial flaring of the eyebrow (HP:0010747) | 2.21705477 |
69 | Failure to thrive in infancy (HP:0001531) | 2.21490577 |
70 | Dysostosis multiplex (HP:0000943) | 2.21481590 |
71 | Broad-based gait (HP:0002136) | 2.21474862 |
72 | Increased circulating renin level (HP:0000848) | 2.19215661 |
73 | Poor eye contact (HP:0000817) | 2.17530174 |
74 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17309758 |
75 | Mucopolysacchariduria (HP:0008155) | 2.17309758 |
76 | Abnormality of renin-angiotensin system (HP:0000847) | 2.13644799 |
77 | Dysautonomia (HP:0002459) | 2.13605470 |
78 | Abnormal pancreas size (HP:0012094) | 2.12925776 |
79 | Dysmetric saccades (HP:0000641) | 2.12371235 |
80 | Genital tract atresia (HP:0001827) | 2.11644473 |
81 | Dysmetria (HP:0001310) | 2.08640641 |
82 | Restlessness (HP:0000711) | 2.07858124 |
83 | Vaginal atresia (HP:0000148) | 2.07640849 |
84 | Fetal akinesia sequence (HP:0001989) | 2.05636109 |
85 | Psychosis (HP:0000709) | 2.05374142 |
86 | Exotropia (HP:0000577) | 2.05331546 |
87 | Menstrual irregularities (HP:0000858) | 2.05311041 |
88 | Congenital primary aphakia (HP:0007707) | 2.05176882 |
89 | Cortical visual impairment (HP:0100704) | 2.04713403 |
90 | Postural tremor (HP:0002174) | 2.01680377 |
91 | Dysdiadochokinesis (HP:0002075) | 2.01261133 |
92 | Deep palmar crease (HP:0006191) | 2.01228350 |
93 | Hemiplegia (HP:0002301) | 2.01116272 |
94 | Postural instability (HP:0002172) | 2.00964742 |
95 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.00861614 |
96 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00515853 |
97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00515853 |
98 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00515853 |
99 | Abnormal social behavior (HP:0012433) | 1.98743054 |
100 | Impaired social interactions (HP:0000735) | 1.98743054 |
101 | Inability to walk (HP:0002540) | 1.97696703 |
102 | Abnormality of potassium homeostasis (HP:0011042) | 1.97627733 |
103 | Abnormality of binocular vision (HP:0011514) | 1.95652530 |
104 | Diplopia (HP:0000651) | 1.95652530 |
105 | Hyperkalemia (HP:0002153) | 1.95273666 |
106 | Osteomalacia (HP:0002749) | 1.94793980 |
107 | Morphological abnormality of the middle ear (HP:0008609) | 1.93416150 |
108 | Congenital glaucoma (HP:0001087) | 1.93279924 |
109 | Hyperparathyroidism (HP:0000843) | 1.92239308 |
110 | Retinal dysplasia (HP:0007973) | 1.91484843 |
111 | Late onset (HP:0003584) | 1.90592089 |
112 | Testicular atrophy (HP:0000029) | 1.90561382 |
113 | Oligodactyly (HP:0012165) | 1.90138063 |
114 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.89727266 |
115 | Abnormal eating behavior (HP:0100738) | 1.89172994 |
116 | Progressive inability to walk (HP:0002505) | 1.88703833 |
117 | Hydroureter (HP:0000072) | 1.88608721 |
118 | Bradykinesia (HP:0002067) | 1.87447130 |
119 | Blue irides (HP:0000635) | 1.86279854 |
120 | Hypothermia (HP:0002045) | 1.86040015 |
121 | Spastic tetraplegia (HP:0002510) | 1.85987284 |
122 | Type II lissencephaly (HP:0007260) | 1.85580716 |
123 | Abnormality of salivation (HP:0100755) | 1.85063391 |
124 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.84985368 |
125 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.84963833 |
126 | Hypoplasia of the brainstem (HP:0002365) | 1.84963833 |
127 | Absent speech (HP:0001344) | 1.84721415 |
128 | Amyotrophic lateral sclerosis (HP:0007354) | 1.84273372 |
129 | Focal dystonia (HP:0004373) | 1.83636618 |
130 | Ulnar claw (HP:0001178) | 1.83173378 |
131 | Septo-optic dysplasia (HP:0100842) | 1.83014029 |
132 | Gaze-evoked nystagmus (HP:0000640) | 1.82706686 |
133 | Nephrogenic diabetes insipidus (HP:0009806) | 1.82625114 |
134 | Generalized myoclonic seizures (HP:0002123) | 1.82428777 |
135 | Limb dystonia (HP:0002451) | 1.81826056 |
136 | Retinal atrophy (HP:0001105) | 1.81661733 |
137 | Abnormality of the lower motor neuron (HP:0002366) | 1.80872112 |
138 | Lissencephaly (HP:0001339) | 1.79181112 |
139 | Oligomenorrhea (HP:0000876) | 1.79035797 |
140 | Hepatoblastoma (HP:0002884) | 1.76049466 |
141 | Aqueductal stenosis (HP:0002410) | 1.75368045 |
142 | Optic nerve hypoplasia (HP:0000609) | 1.73896180 |
143 | Specific learning disability (HP:0001328) | 1.73753345 |
144 | Paraplegia (HP:0010550) | 1.73632742 |
145 | Labial hypoplasia (HP:0000066) | 1.72124534 |
146 | Incomplete penetrance (HP:0003829) | 1.70956242 |
147 | Cutaneous finger syndactyly (HP:0010554) | 1.68915895 |
148 | Anophthalmia (HP:0000528) | 1.65544506 |
149 | Insidious onset (HP:0003587) | 1.64729133 |
150 | Termporal pattern (HP:0011008) | 1.64729133 |
151 | Scanning speech (HP:0002168) | 1.64595337 |
152 | True hermaphroditism (HP:0010459) | 1.64392544 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.51354194 |
2 | INSRR | 4.24455619 |
3 | PRKD3 | 3.49383947 |
4 | EPHA4 | 2.86077086 |
5 | MAP3K4 | 2.73127712 |
6 | CASK | 2.69734251 |
7 | RIPK4 | 2.39931266 |
8 | MAP3K9 | 2.37517121 |
9 | MARK1 | 2.34419079 |
10 | MAP2K7 | 2.32598968 |
11 | NTRK1 | 2.17139132 |
12 | MAP3K12 | 2.13291589 |
13 | MINK1 | 1.98965716 |
14 | MAP4K2 | 1.96882134 |
15 | MAP3K2 | 1.95658600 |
16 | MAPK15 | 1.92447879 |
17 | PASK | 1.88962379 |
18 | CAMKK2 | 1.82649096 |
19 | PNCK | 1.82429402 |
20 | DAPK2 | 1.80079788 |
21 | UHMK1 | 1.76668307 |
22 | MAP2K4 | 1.68611159 |
23 | DYRK2 | 1.64915384 |
24 | CCNB1 | 1.61317007 |
25 | GRK5 | 1.53335120 |
26 | WNK4 | 1.49291397 |
27 | TAOK3 | 1.42097409 |
28 | HIPK2 | 1.41973533 |
29 | NTRK2 | 1.41949939 |
30 | FRK | 1.40436445 |
31 | CDK5 | 1.37005312 |
32 | PLK2 | 1.36778859 |
33 | BMPR2 | 1.36161710 |
34 | BRAF | 1.33880560 |
35 | MAPK13 | 1.29648548 |
36 | AKT3 | 1.29313799 |
37 | TNIK | 1.28976389 |
38 | WNK3 | 1.27275714 |
39 | DAPK1 | 1.26631857 |
40 | PAK6 | 1.22355268 |
41 | TRIM28 | 1.21603321 |
42 | CSNK1G3 | 1.20508525 |
43 | CSNK1A1L | 1.19755769 |
44 | KSR2 | 1.17540318 |
45 | CAMKK1 | 1.16705061 |
46 | PRKCH | 1.12507837 |
47 | CAMK2B | 1.11263814 |
48 | PRKCG | 1.10884113 |
49 | PAK3 | 1.08093534 |
50 | CSNK1G1 | 1.06620033 |
51 | MAP3K1 | 1.03605490 |
52 | CAMK2A | 1.03208237 |
53 | CDC42BPA | 1.00548434 |
54 | SIK2 | 1.00367761 |
55 | PRKCE | 0.94795578 |
56 | ARAF | 0.94374837 |
57 | EPHA3 | 0.88000918 |
58 | FES | 0.86790804 |
59 | CAMK2D | 0.85300973 |
60 | LATS2 | 0.84091914 |
61 | PINK1 | 0.83640032 |
62 | NME1 | 0.82652741 |
63 | PKN1 | 0.81071919 |
64 | DYRK1A | 0.80812352 |
65 | PRKD2 | 0.78356651 |
66 | ERBB3 | 0.77354944 |
67 | KSR1 | 0.77244650 |
68 | FER | 0.76334528 |
69 | SCYL2 | 0.72147162 |
70 | WNK1 | 0.67207496 |
71 | GRK7 | 0.66502136 |
72 | CDK11A | 0.65484246 |
73 | SGK494 | 0.64658543 |
74 | SGK223 | 0.64658543 |
75 | BMPR1B | 0.62465639 |
76 | PRPF4B | 0.61940839 |
77 | TYRO3 | 0.58467613 |
78 | SGK1 | 0.58353593 |
79 | CSNK1D | 0.57042063 |
80 | RET | 0.56894896 |
81 | MARK2 | 0.56572875 |
82 | BCR | 0.55207326 |
83 | SGK2 | 0.53025619 |
84 | ADRBK1 | 0.52207310 |
85 | CAMK1 | 0.51336108 |
86 | CDK14 | 0.51092232 |
87 | PDPK1 | 0.50523492 |
88 | STK11 | 0.49329015 |
89 | CSNK1G2 | 0.49092895 |
90 | CSNK1E | 0.47880443 |
91 | MAP2K2 | 0.47489722 |
92 | PRKACA | 0.46530707 |
93 | STK38 | 0.46360601 |
94 | CAMK2G | 0.45653692 |
95 | SGK3 | 0.45357994 |
96 | RPS6KA3 | 0.44270583 |
97 | MAP2K1 | 0.42984468 |
98 | PRKG1 | 0.42597054 |
99 | CAMK4 | 0.42366310 |
100 | PDGFRA | 0.40446111 |
101 | RPS6KA2 | 0.39814667 |
102 | MAP3K13 | 0.39787117 |
103 | PHKG2 | 0.39077861 |
104 | PHKG1 | 0.39077861 |
105 | PRKCZ | 0.38839683 |
106 | CDK19 | 0.38626303 |
107 | MAPK10 | 0.37513812 |
108 | CSNK1A1 | 0.36899043 |
109 | PTK2B | 0.36609482 |
110 | PDK1 | 0.36405631 |
111 | RAF1 | 0.36270576 |
112 | CDK18 | 0.36194131 |
113 | PRKAA1 | 0.36176300 |
114 | STK39 | 0.35976244 |
115 | PRKCA | 0.34498691 |
116 | CDK15 | 0.34364162 |
117 | MAPK12 | 0.33997164 |
118 | NEK6 | 0.33789897 |
119 | OXSR1 | 0.33709381 |
120 | PRKCB | 0.33510742 |
121 | IRAK2 | 0.33509301 |
122 | PTK2 | 0.33405066 |
123 | TAOK1 | 0.33311855 |
124 | PRKACG | 0.32780272 |
125 | FYN | 0.32752866 |
126 | BRSK1 | 0.32277447 |
127 | ROCK2 | 0.31746551 |
128 | PRKACB | 0.31536987 |
129 | FGR | 0.31408031 |
130 | GSK3B | 0.31096572 |
131 | MKNK2 | 0.30478070 |
132 | PRKDC | 0.30076344 |
133 | RPS6KB1 | 0.27483840 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.97599116 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.13584961 |
3 | Insulin secretion_Homo sapiens_hsa04911 | 3.01868675 |
4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.81168002 |
5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.58336851 |
6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.41888675 |
7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.41596220 |
8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.40800992 |
9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.29821762 |
10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.17700001 |
11 | Taste transduction_Homo sapiens_hsa04742 | 2.17463049 |
12 | Morphine addiction_Homo sapiens_hsa05032 | 2.13520332 |
13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.06303303 |
14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.05222514 |
15 | Protein export_Homo sapiens_hsa03060 | 2.01973399 |
16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.99741015 |
17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.98874504 |
18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.84376497 |
19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.82211640 |
20 | Olfactory transduction_Homo sapiens_hsa04740 | 1.78112770 |
21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.72714337 |
22 | Salivary secretion_Homo sapiens_hsa04970 | 1.69913639 |
23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.69199153 |
24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.68021593 |
25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67075298 |
26 | Renin secretion_Homo sapiens_hsa04924 | 1.60292182 |
27 | Long-term depression_Homo sapiens_hsa04730 | 1.55882458 |
28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.51647022 |
29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43064637 |
30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38125860 |
31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.33218944 |
32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.26664604 |
33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.25775751 |
34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.23536767 |
35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.23499866 |
36 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.23325214 |
37 | Alzheimers disease_Homo sapiens_hsa05010 | 1.18965175 |
38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17976496 |
39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16205688 |
40 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.11619553 |
41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11166416 |
42 | Gap junction_Homo sapiens_hsa04540 | 1.09928160 |
43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.07585530 |
44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06334048 |
45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03624300 |
46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00385555 |
47 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.00221790 |
48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99034894 |
49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96122138 |
50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94272910 |
51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.93192091 |
52 | Melanogenesis_Homo sapiens_hsa04916 | 0.92451730 |
53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91300654 |
54 | Parkinsons disease_Homo sapiens_hsa05012 | 0.82816248 |
55 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.80837617 |
56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78913414 |
57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78824205 |
58 | Prion diseases_Homo sapiens_hsa05020 | 0.77921553 |
59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76584701 |
60 | Glioma_Homo sapiens_hsa05214 | 0.76004855 |
61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72533297 |
62 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72045708 |
63 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66956364 |
64 | Phototransduction_Homo sapiens_hsa04744 | 0.63284101 |
65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61192299 |
66 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59353462 |
67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59246794 |
68 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58726311 |
69 | Axon guidance_Homo sapiens_hsa04360 | 0.56856038 |
70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55559477 |
71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54643506 |
72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54476869 |
73 | Alcoholism_Homo sapiens_hsa05034 | 0.54289673 |
74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54072242 |
75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53698302 |
76 | Lysosome_Homo sapiens_hsa04142 | 0.52294161 |
77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50918440 |
78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49482603 |
79 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49291045 |
80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47425726 |
81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46882415 |
82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46332750 |
83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45685067 |
84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43766324 |
85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.43557966 |
86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43009056 |
87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42712582 |
88 | Bile secretion_Homo sapiens_hsa04976 | 0.42463554 |
89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41959893 |
90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41459712 |
91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39560786 |
92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39506834 |
93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39236045 |
94 | Tight junction_Homo sapiens_hsa04530 | 0.38668646 |
95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37521482 |
96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37101346 |
97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36793564 |
98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35515791 |
99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35454556 |
100 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35340520 |
101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35121191 |
102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34876065 |
103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34758153 |
104 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.33746049 |
105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33609475 |
106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33093036 |
107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32411956 |
108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.32325501 |
109 | Phagosome_Homo sapiens_hsa04145 | 0.32069090 |
110 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32031344 |
111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31529172 |
112 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30228359 |
113 | ABC transporters_Homo sapiens_hsa02010 | 0.29809288 |
114 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29494836 |
115 | Basal transcription factors_Homo sapiens_hsa03022 | 0.29463466 |
116 | Insulin resistance_Homo sapiens_hsa04931 | 0.28586704 |
117 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.27592696 |
118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.26114129 |
119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25916993 |
120 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24966038 |
121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23344124 |
122 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.20206633 |